Future therapeutic targets in mood disorders: the glucocorticoid receptor
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Background: The hypercortisolaemia and dysfunction of the hypothalamic–pituitary–adrenal (HPA) axis associated with mood disorders have been attributed to a breakdown in the glucocorticoid-receptor-mediated negative feedback mechanism regulating HPA activity. Reinstating normal feedback may be therapeutic in mood disorders. Aims: To review the evidence for the involvement of the glucocorticoid receptor in the pathogenesis and treatment of mood disorders. Method: Medline and hand searches were carried out, selecting literature relevant to psychiatrists and psychopharmacologists. Results: A dysfunction in glucocorticoid receptors is integral to the HPA abnormalities of mood disorders. Antidepressant and mood-stabilising drugs can up-regulate glucocorticoid receptors, restoring glucocorticoid function. Preliminary clinical studies targeting the glucocorticoid receptor are encouraging. Conclusions: Drugs designed specifically to up-regulate glucocorticoid receptors may be integral to future strategies in treating mood disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The neuroendocrinology of stress and aging: The glucocorticoid cascade hypothesis
SAPOLSKY, R. M., KREY, L. C., & McEWEN, B. S. (1986) · Endocrine Reviews · doi:10.1210/edrv-7-3-284 · Cited by 2,298
JACOBSON, L., & SAPOLSKY, R. (1991) · Endocrine Reviews · doi:10.1210/edrv-12-2-118 · Cited by 1,739
Nemeroff, C. B., Widerlöv, E., Bissette, G., Walléus, H., Karlsson, I., Eklund, K., Kilts, C. D., Loosen, P. T., & Vale, W. (1984) · Science · doi:10.1126/science.6334362 · Cited by 1,485
The acute effects of corticosteroids on cognition: integration of animal and human model studies
LUPIEN, S., & MCEWEN, B. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00004-0 · Cited by 1,024
The combined dexamethasone/CRH test: A refined laboratory test for psychiatric disorders
Heuser, I., Yassouridis, A., & Holsboer, F. (1994) · Journal of Psychiatric Research · doi:10.1016/0022-3956(94)90017-5 · Cited by 662
Holsboer, F. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(98)90056-5 · Cited by 654
Double-blind treatment of major depression with dehydroepiandrosterone.
Wolkowitz, O. M., Reus, V. I., Keebler, A., Nelson, N., Friedland, M., Brizendine, L., & Roberts, E. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.4.646 · Cited by 411
Deuschle, M., Schweiger, U., Weber, B., Gotthardt, U., Körner, A., Schmider, J., Standhardt, H., Lammers, C.-H., & Heuser, I. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.1.3689 · Cited by 344
Dehydroepiandrosterone treatment of midlife dysthymia∗∗See accompanying Editorial, in this issue.
Bloch, M., Schmidt, P. J., Danaceau, M. A., Adams, L. F., & Rubinow, D. R. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00066-9 · Cited by 179
Steroid-Independent Translocation of the Glucocorticoid Receptor by the Antidepressant Desipramine
Pariante, C. M., Pearce, B. D., Pisell, T. L., Owens, M. J., & Miller, A. H. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.4.571 · Cited by 156
Cited by
Inflamed moods: A review of the interactions between inflammation and mood disorders
Rosenblat, J. D., Cha, D. S., Mansur, R. B., & McIntyre, R. S. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.01.013 · Cited by 609
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Manji, H. K., Quiroz, J. A., Sporn, J., Payne, J. L., Denicoff, K., A. Gray, N., Zarate, C. A., & Charney, D. S. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00117-3 · Cited by 505
Charney, D. S., & Manji, H. K. (2004) · Science's STKE · doi:10.1126/stke.2252004re5 · Cited by 429
van Praag, H. M. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.05.031 · Cited by 377
Young, A. H., Gallagher, P., Watson, S., Del-Estal, D., Owen, B. M., & Nicol Ferrier, I. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300471 · Cited by 318
“It has been suggested that abnormalities in hypothalamic–pituitary– adrenal (HPA) axis function may cause or exacerbate both neurocognitive impairment and depressive symptoms (McQuade and Young, 2000; Sapolsky, 2000).”
BackgroundInfluentialSelf-citationThe Concept of Depression as a Dysfunction of the Immune System
E. Leonard, B. (2010) · Current Immunology Reviews · doi:10.2174/157339510791823835 · Cited by 276
Sex differences in psychopathology: of gonads, adrenals and mental illness
Solomon, M. B., & Herman, J. P. (2009) · Physiology & Behavior · doi:10.1016/j.physbeh.2009.02.033 · Cited by 272
“depression-like behavior, triggering clinical trials of the antidepressant efficacy of glucocorticoid receptor antagonists [81].”
Early-life stress and HPA axis trigger recurrent adulthood depression
Juruena, M. F. (2014) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2013.10.020 · Cited by 253
Do antidepressants regulate how cortisol affects the brain?
Pariante, C. M., Thomas, S. A., Lovestone, S., Makoff, A., & Kerwin, R. W. (2004) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2003.10.009 · Cited by 194
Videbech, P., Ravnkilde, B., Pedersen, T. H., Hartvig, H., Egander, A., Clemmensen, K., Rasmussen, N. A., Andersen, F., Gjedde, A., & Rosenberg, R. (2002) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2002.02245.x · Cited by 161
Pariante, C. M., Makoff, A., Lovestone, S., Feroli, S., Heyden, A., Miller, A. H., & Kerwin, R. W. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704368 · Cited by 159
“…that antidepressants exert their clinical e ects through direct modulation of the glucocorticoid receptor (GR) is one of the most striking and innovative models of the mechanism of action of this class of drugs (Barden, 1999; Holsboer, 2000; McQuade & Young, 2000; Pariante & Miller, 2001).”
BackgroundGlucocorticoid Receptor Function In Vitro in Patients with Major Depression
Pariante, C. M. (2004) · Stress · doi:10.1080/10253890500069650 · Cited by 147
Hypothalamic–pituitary–adrenal axis function in patients with chronic depression
WATSON, S., GALLAGHER, P., DEL-ESTAL, D., HEARN, A., FERRIER, I. N., & YOUNG, A. H. (2002) · Psychological Medicine · doi:10.1017/s0033291702005998 · Cited by 130
Self-citationYoung, A. H. (2004) · Stress · doi:10.1080/10253890500069189 · Cited by 111
“The dexamethasone suppression test (DST) is a measure of the functional integrity of the GR-mediated negative feedback mechanism: the cortisol-suppressing activity of the synthetic glucocorticoid, dexamethasone, is an approximate indicator of GR status (McQuade and Young 2000).”
BackgroundSelf-citationColla, M., Schubert, F., Bubner, M., Heidenreich, J. O., Bajbouj, M., Seifert, F., Luborzewski, A., Heuser, I., & Kronenberg, G. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.26 · Cited by 106
Depression and stress: a biopsychosocial exploration of evolved functions and mechanisms
Gilbert, P. (2001) · Stress · doi:10.3109/10253890109115726 · Cited by 92
“Indicators of chronic physiological stress, as shown by hypercortisolaemia and autonomic nervous system, parasympathetic hyperarousal, is common in major depression (Levitan et al., 2000; McGuade and Young, 2000; Nemeroff, 1996, 1998; Raadsheer et al., 1994; Toates, 1995).”
BackgroundKhundakar, A. A., & Thomas, A. J. (2009) · International Psychogeriatrics · doi:10.1017/s104161020999007x · Cited by 50
“Enhanced glucocorticoid levels, as a result of hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis, have been implicated in the pathophysiology of MDD (McQuade and Young, 2000).”
BackgroundThiazolidinediones: novel treatments for cognitive deficits in mood disorders?
McIntyre, R. S., Soczynska, J. K., Woldeyohannes, H. O., Lewis, G. F., Leiter, L. A., MacQueen, G. M., Miranda, A., Fulgosi, D., Konarski, J. Z., & Kennedy, S. H. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.11.1615 · Cited by 32
“5 Glucocorticoids: a salient mediator in mood disorders Abnormalities in hypothalamic–pituitary–adrenal (HPA) axis function may engender or exacerbate cognitive impairment and depressive symptoms [93-96] .”
BackgroundWatson, S., Thompson, J. M., Malik, N., Nicol Ferrier, I., & Young, A. H. (2005) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2005.01560.x · Cited by 19
Self-citation
Metadata
- Authors
- McQuade, R., & Young, A. H.
- Venue
- British Journal of Psychiatry
- Publisher
- Royal College of Psychiatrists
- Published
- 2000-11
- Volume
- 177
- Issue
- 5
- Pages
- 390-395
- ISSN
- 0007-1250 (ISSN-L)
- 1472-1465
- OpenAlex
- W2121712335
- Cited by
- 156
- References
- 12
- FWCI
- 3.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.